Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Hall

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Blood|April 2, 2020
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical TrialHeiko Schöder, Mei-Yin C Polley, Michael V Knopp, et al.
Digestive Diseases and Sciences|December 26, 2024
Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data ResourceChen Yanover, Ramit Magen-Rimon, Erica A Voss, et al.
Blood|June 28, 2015
Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 studySamantha M Jaglowski, Jeffrey A Jones, Veena Nagar, et al.
BMC Public Health|October 5, 2018
Cardiorespiratory fitness is associated with physical literacy in a large sample of Canadian children aged 8 to 12 yearsJustin J Lang, Jean-Philippe Chaput, Patricia E Longmuir, et al.
The Oncologist|May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker StudyRobert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.
Ophthalmology. Retina|March 22, 2024
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network StudyCindy X Cai, Akihiko Nishimura, Mary G Bowring, et al.
Nature|May 29, 2015
Whole-genome characterization of chemoresistant ovarian cancerAnn-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam, et al.
Nature|October 28, 2015
Corrigendum: Whole-genome characterization of chemoresistant ovarian cancerAnn-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Blood|April 2, 2020
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical TrialHeiko Schöder, Mei-Yin C Polley, Michael V Knopp, et al.
Digestive Diseases and Sciences|December 26, 2024
Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data ResourceChen Yanover, Ramit Magen-Rimon, Erica A Voss, et al.
Blood|June 28, 2015
Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 studySamantha M Jaglowski, Jeffrey A Jones, Veena Nagar, et al.
BMC Public Health|October 5, 2018
Cardiorespiratory fitness is associated with physical literacy in a large sample of Canadian children aged 8 to 12 yearsJustin J Lang, Jean-Philippe Chaput, Patricia E Longmuir, et al.
The Oncologist|May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker StudyRobert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.
Ophthalmology. Retina|March 22, 2024
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network StudyCindy X Cai, Akihiko Nishimura, Mary G Bowring, et al.
Nature|May 29, 2015
Whole-genome characterization of chemoresistant ovarian cancerAnn-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam, et al.
Nature|October 28, 2015
Corrigendum: Whole-genome characterization of chemoresistant ovarian cancerAnn-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam, et al.
Pageof 9